100 related articles for article (PubMed ID: 8384544)
1. Susceptibility of Brucella melitensis to the new fluoroquinolone PD 131628: comparison with other drugs.
Qadri SM; Ueno Y
Chemotherapy; 1993; 39(2):128-31. PubMed ID: 8384544
[TBL] [Abstract][Full Text] [Related]
2. Anti-Brucella activity of Ro 23-9424, a dual-action antibacterial.
Qadri SM; Ueno Y; Ayub A
Chemotherapy; 1993; 39(6):386-9. PubMed ID: 8222864
[TBL] [Abstract][Full Text] [Related]
3. Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones.
García-Rodríguez JA; García Sánchez JE; Trujillano I; García Sánchez E; García García MI; Fresnadillo MJ
Antimicrob Agents Chemother; 1995 May; 39(5):1194-5. PubMed ID: 7625815
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of Salmonella typhi and Brucella melitensis to the new fluoroquinolone rufloxacin (MF 934).
Qadri SM; Ayub A; Ueno Y; Saldin H
Chemotherapy; 1993; 39(5):311-4. PubMed ID: 8396527
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Brucella melitensis to fluoroquinolones.
Qadri SM; Akhtar M; Ueno Y; al-Sibai MB
Drugs Exp Clin Res; 1989; 15(10):483-5. PubMed ID: 2632216
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
Kilic S; Dizbay M; Cabadak H
J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of azithromycin against Brucella melitensis.
Qadri SM; Halim MA; Ueno Y; Abumustafa FM; Postle AG
Chemotherapy; 1995; 41(4):253-6. PubMed ID: 7555205
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of lomefloxacin against Brucella melitensis.
Qadri SM; al-Sedairy S; Ueno Y
Diagn Microbiol Infect Dis; 1990; 13(3):277-9. PubMed ID: 2383977
[TBL] [Abstract][Full Text] [Related]
11. In vitro selection of fluoroquinolone resistance in Brucella melitensis.
Ravanel N; Gestin B; Maurin M
Int J Antimicrob Agents; 2009 Jul; 34(1):76-81. PubMed ID: 19261448
[TBL] [Abstract][Full Text] [Related]
12. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
[TBL] [Abstract][Full Text] [Related]
14. Activity of BAY y 3118, a novel 4-quinolone, against Brucella melitensis.
García-Rodríguez JA; García-Sánchez JE; Trujillano-Martín I; García-Sánchez E; García-García MI; Fresnadillo MJ
J Chemother; 1994 Apr; 6(2):102-6. PubMed ID: 8077983
[TBL] [Abstract][Full Text] [Related]
15. Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis.
Valdezate S; Navarro A; Medina-Pascual MJ; Carrasco G; Saéz-Nieto JA
J Antimicrob Chemother; 2010 Jan; 65(1):51-3. PubMed ID: 19861338
[TBL] [Abstract][Full Text] [Related]
16. Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin.
Barry AL; Fuchs PC; Citron DM; Allen SD; Wexler HM
J Antimicrob Chemother; 1993 Jun; 31(6):893-900. PubMed ID: 8395494
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
18. [Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].
Keşli R; Bilgin H; Yılmaz H
Mikrobiyol Bul; 2017 Jul; 51(3):260-268. PubMed ID: 28929962
[TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey.
Kocagöz S; Akova M; Altun B; Gür D; Hasçelik G
Clin Microbiol Infect; 2002 Apr; 8(4):240-2. PubMed ID: 12047416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
